We are live on
!
Find out more
ISL
Ingalls & Snyder LLC Portfolio holdings
AUM
$2.83B
1-Year Est. Return
21.61%
This Fund
S&P 500
This Quarter
Est. Return
-3.01%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.05B
AUM Growth
-$123M
(-5.6%)
Cap. Flow
-$5.89M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
33.53%
Holding
421
New
18
Increased
105
Reduced
170
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$11.8M |
| 2 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
+$11M |
| 3 |
Apple
AAPL
|
+$8.35M |
| 4 |
Allison Transmission
ALSN
|
+$8.29M |
| 5 |
Liberty Latin America Class A
LILA
|
+$6.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$10.2M |
| 2 |
JPMorgan Chase
JPM
|
+$10.1M |
| 3 |
Emerson Electric
EMR
|
+$6.93M |
| 4 |
GE Aerospace
GE
|
+$4.16M |
| 5 |
General Motors
GM
|
+$3.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.19% |
| 2 | Healthcare | 16.97% |
| 3 | Industrials | 11.47% |
| 4 | Financials | 11.38% |
| 5 | Technology | 8.47% |
Similar funds
GS
SL
AF
SIC
ADEF
AIP
SAI
FISPB
Ingalls & Snyder LLC's Q1 2018 Portfolio in Review
As of Q1 2018, Ingalls & Snyder LLC held 421 positions worth $2.05B, down 5.6% from $2.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ingalls & Snyder LLC's Q1 2018 filing shows 18 new, 105 increased, 170 reduced and 14 closed positions. Its largest new stake was Allison Transmission: 199,769 shares worth $7.8M. The largest sale was RTX Corp, an estimated $10.2M.
By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.
- Ingalls & Snyder LLC's largest Q1 2018 buy was Allison Transmission: 199,769 shares worth $7.8M.
- Ingalls & Snyder LLC added most to Canadian Natural Resources in Q1 2018, an estimated $11.8M increase.
- Ingalls & Snyder LLC's biggest Q1 2018 reduction was RTX Corp, cutting an estimated $10.2M.
- Ingalls & Snyder LLC fully exited Regeneron Pharmaceuticals in Q1 2018, selling an estimated $2.32M.
- Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.05B portfolio in Q1 2018.
- Ingalls & Snyder LLC opened 18 new positions and closed 14 in Q1 2018.
- Ingalls & Snyder LLC's portfolio value fell 5.6% quarter-over-quarter to $2.05B.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2018, filed 17 Apr 2018.